HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

475.517

+6.4061.37%

Number of Gainers:24

Number of Losers:25

Number of Flat:2

PE:- -

High:479.862

Open:468.227

Low:465.418

Close:469.111

Volume:368.12M

Turnover:10.79B

Market Cap:2.98T

Float Cap:2.09T

Loading ...

Junshi Biosciences Raises 700 Million Yuan Through Tech Innovation Bond Issuance

China's Henlius H1 Revenue Jumps on Drug Sales, License Income

Jefferies Adjusts Fuyao Glass Industry Group's Price Target to HK$73.70 From HK$78.10, Keeps at Buy

MT Newswires Live

Antengene-B Turns Profitable in First Half with Net Income of RMB216 Million

Simcere Pharmaceutical Grants 795,000 RSUs Under 2021 Share Award Scheme

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

JXR Reports Interim Results with Return to Profitability

Antengene FY26 H1 Returns to Profit at RMB 216.35 Million; Revenue More than Doubled to RMB 513.08 Million

Antengene Corporation H1 Net Income Attributable RMB 216.3 Million

THOMSON REUTERS

China's Jinxin Fertility Group Interim Revenue Rises on U.S. IVF Demand

Jinxin Fertility FY26 H1 Swings to Profit of RMB 110.3 Million; Revenue Rises 6.6% to RMB 1.37 Billion

Jinxin Fertility Group H1 Net Income Attributable RMB 107.4 Million

THOMSON REUTERS

Guizhou Unveils 13 Typical Cases of Consumer Rights Violations in Market Regulation Crackdown

JD Health International Stock Rallies 1.6% in Hong Kong

Hansoh Pharmaceutical Group Stock Sheds 1.8% in Hong Kong

AH Share Premium Tracker | August 21 Market Close

Citi Raises Keymed Bio's Target Price to HK$97.5, Maintains Buy/High-Risk Rating

3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion

Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth

Norway's Medistim Q2 Revenue Rises on Own-Product Sales Growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK1583/news?page=24"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":475.51715,"timestamp":1788336485493,"preClose":469.11102,"halted":0,"volume":368124380,"delay":0,"changeRate":0.013656,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":6.406128,"latestTime":"09-02 16:00:00","open":468.22687,"high":479.86185,"low":465.4181,"amount":10792750243.5,"amplitude":0.03079,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"pbRate":2.123393,"peRate":44.857386,"turnoverRate":0.003434,"increases":23,"decrements":25,"flats":1,"marketCap":2976863298400,"floatMarketCap":2091188461088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":479.86185,"amplitude":0.03079,"preClose":469.11102,"low":465.4181,"pbRate":"2.123393","latestPrice":475.51715,"volume":368124380,"delay":0,"open":468.22687,"prevYearClose":503.90085,"prevWeekClose":483.681,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":483.092,"twentyDayClose":476.028,"sixtyDayClose":414.418,"secType":"PLATE","market":"HK","turnoverRate":0.003434,"peRate":44.857386,"marketCap":2976863298400,"floatMarketCap":2091188461088,"timestamp":1788336485493,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":24,"down":25,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:24,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1120137209","title":"Junshi Biosciences Raises 700 Million Yuan Through Tech Innovation Bond Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=1120137209","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120137209?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:50","pubTimestamp":1787313012,"startTime":"0","endTime":"0","summary":"Junshi Biosciences (01877) has announced the successful completion of its third technology innovation bond issuance for the 2026 fiscal year, with the raised funds credited to the company's account...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNDW","01877","BK1583","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267758","title":"China's Henlius H1 Revenue Jumps on Drug Sales, License Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267758","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661267758?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:36","pubTimestamp":1787312209,"startTime":"0","endTime":"0","summary":"China's Henlius H1 revenue jumps on drug sales, license incomeOverviewChina biopharma firm's interim revenue rose 27% yr/yr, driven by drug sales and licensingCompany expanded global footprint with ne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","06996","00656","HK0000320264.USD","BK1230","HK0000306685.HKD","BK1583","HK0000306701.USD","BK1191","BK1574","02696","06855","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661152262","title":"Jefferies Adjusts Fuyao Glass Industry Group's Price Target to HK$73.70 From HK$78.10, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661152262","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661152262?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:55","pubTimestamp":1787309704,"startTime":"0","endTime":"0","summary":"Fuyao Glass Industry Group (HKG:3606) has an average rating of buy and mean price target of HK$77.62, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resear","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0051755006.USD","LU0972618739.USD","LU2177674079.SGD","LU0509642566.USD","LU2242644610.SGD","03606","LU0502904849.HKD","IE00B031HY20.USD","BK1509","LU0455707207.USD","BK1144","IE0008368742.USD","LU1171460220.USD","LU0828238088.HKD","LU2279858448.HKD","LU1655091616.SGD","IE0034224299.USD","BK1554","LU0327786744.USD","LU1785774172.SGD","LU2008162690.USD","LU0456827905.SGD","BK1583","BK1594","LU0572944931.SGD","IE0008369823.USD","LU0269904917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122991385","title":"Antengene-B Turns Profitable in First Half with Net Income of RMB216 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1122991385","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122991385?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:46","pubTimestamp":1787309190,"startTime":"0","endTime":"0","summary":"Antengene-B (06996) has reported a strong turnaround in its interim results for the six months ended June 30, 2026, achieving a net profit of RMB216 million compared to a loss in the prior year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1191","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262313","title":"Simcere Pharmaceutical Grants 795,000 RSUs Under 2021 Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661262313?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:45","pubTimestamp":1787309108,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical grants 795,000 RSUs under 2021 share award schemeSimcere Pharmaceutical Group granted 795,000 RSUs under its 2021 RSU Scheme to eight employee participants.Awards carry nil purc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLc69X2W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264711","title":"Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264711","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264711?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:38","pubTimestamp":1787308735,"startTime":"0","endTime":"0","summary":"Biotech firm Antengene's H1 revenue jumps on licensing dealsOverviewBiotech company's H1 revenue rose sharply on licensing deals with UCB, K2 TherapeuticsCompany swung to H1 net profit from loss a yea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0AK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996","BK1574","02137","06855","BK1191","BK1583","BK1161","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143973557","title":"JXR Reports Interim Results with Return to Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=1143973557","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143973557?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:28","pubTimestamp":1787308107,"startTime":"0","endTime":"0","summary":"JXR (01951) has announced its financial results for the six months ended June 30, 2026, posting a revenue of RMB 1.373 billion, representing a year-on-year increase of 6.57%. The company achieved a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1219","BK1597","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264647","title":"Antengene FY26 H1 Returns to Profit at RMB 216.35 Million; Revenue More than Doubled to RMB 513.08 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264647","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264647?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:27","pubTimestamp":1787308044,"startTime":"0","endTime":"0","summary":"Antengene FY26 H1 returns to profit at RMB 216.35 million; revenue more than doubled to RMB 513.08 millionAntengene posted IFRS revenue of RMB 513.08 million, up RMB 459.9 million, for the six months ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL22M2ss:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","06996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661326464","title":"Antengene Corporation H1 Net Income Attributable RMB 216.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661326464","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661326464?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:27","pubTimestamp":1787308040,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nPLXC5NLS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1191","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264564","title":"China's Jinxin Fertility Group Interim Revenue Rises on U.S. IVF Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264564","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264564?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:23","pubTimestamp":1787307829,"startTime":"0","endTime":"0","summary":"China's Jinxin Fertility Group interim revenue rises on U.S. IVF demandOverviewChina fertility clinic operator's interim revenue for six months to June 30 grew 6.6% yr/yrNet profit for the six months ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951","BK1219","02190","BK1574","BK1100","BK1587","BK1583","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661261796","title":"Jinxin Fertility FY26 H1 Swings to Profit of RMB 110.3 Million; Revenue Rises 6.6% to RMB 1.37 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2661261796","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661261796?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:11","pubTimestamp":1787307078,"startTime":"0","endTime":"0","summary":"Jinxin Fertility FY26 H1 swings to profit of RMB 110.3 million; revenue rises 6.6% to RMB 1.37 billionJinxin Fertility posted IFRS net profit of RMB 110.3 million, returning to profit from a prior-yea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLb5cyYv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","BK1597","BK1583","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226175","title":"Jinxin Fertility Group H1 Net Income Attributable RMB 107.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226175?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:10","pubTimestamp":1787307050,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nPLXQMSPMF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01951","BK1219","BK1583","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151570295","title":"Guizhou Unveils 13 Typical Cases of Consumer Rights Violations in Market Regulation Crackdown","url":"https://stock-news.laohu8.com/highlight/detail?id=1151570295","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151570295?lang=en_us&edition=fundamental","pubTime":"2026-08-21 16:52","pubTimestamp":1787302339,"startTime":"0","endTime":"0","summary":"In recent years, market regulatory authorities in Guizhou Province have continuously carried out the \"Guardian of Consumption\" enforcement campaign, cracking down on illegal activities that have...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDEV","MEDX","LGHT","RSPH","AGNG","LNGR","IEIH","BK1574","PTH","HART","GDOC","09996","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661263074","title":"JD Health International Stock Rallies 1.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661263074","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661263074?lang=en_us&edition=fundamental","pubTime":"2026-08-21 16:33","pubTimestamp":1787301180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. rose 1.6% to 38.66 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 26009.46.JD Health International Inc. closed 46% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 9.1 million shares, compared to the 50-day average of 10.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1142","BK1615","BK1591","BK1589","SGXZ62798434.SGD","86618","LU0051755006.USD","BK1247","LU0456827905.SGD","BK1515","06618","BK1571","SGXZ86797644.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661263001","title":"Hansoh Pharmaceutical Group Stock Sheds 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661263001","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661263001?lang=en_us&edition=fundamental","pubTime":"2026-08-21 16:33","pubTimestamp":1787301180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. shed 1.8% to 33.08 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 26009.46.The stock's fall snapped a two-day winning streak.Hansoh Pharmaceutical Group Co. Ltd. closed 25% short of its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 12.7 million shares, compared to the 50-day average of 12.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","03692","BK1589","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179668361","title":"AH Share Premium Tracker | August 21 Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1179668361","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179668361?lang=en_us&edition=fundamental","pubTime":"2026-08-21 16:21","pubTimestamp":1787300495,"startTime":"0","endTime":"0","summary":"As of the August 21 market close, the latest AH premium rankings reveal notable divergences between dual-listed stocks on the Hong Kong and mainland exchanges. NE ELECTRIC (00042), ZHEJIANG SHIBAO...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0328353924.USD","02768","BK1558","LU0320764755.SGD","LU2125910500.SGD","LU0329678170.USD","LU0589944569.HKD","IE0032431581.USD","01033","BK1515","LU0540923850.HKD","LU1770034418.SGD","HK0000352382.USD","LU0456846285.SGD","LU0106959298.USD","LU1244550494.USD","LU0431992006.USD","LU0531970944.HKD","BK1522","LU1008478684.HKD","BK1144","LU0244354667.USD","LU1105468828.SGD","06745","LU0229945570.USD","IE00B543WZ88.USD","00553","BK1240","00300","HK0001040168.HKD","LU0326950275.SGD","03296","EWH","LU0543330566.HKD","IE00BYV24P56.USD","BK1523","LU1023057109.AUD","LU0359201885.HKD","LU0456854461.SGD","LU1064131342.USD","BK1610","82846","BK1533","LU1366334651.USD","IE00BGHQDM52.EUR","LU0106252389.USD","BK1526","BK1193","BK1209","BK1122","LU0979878070.USD","LU0449515922.USD","BK1544","LU0890818403.SGD","LU0228659784.USD","03143","BK1614","LU2097828631.EUR","LU0214875030.USD","02359","LU2476274308.USD","LU2226246903.HKD","00638","LU0640798160.USD","LU1504937902.USD","IE0031814852.USD","BK1183","LU0348767384.USD","LU0345780521.USD","03968","LU0269904917.USD","LU0516423174.USD","LU1242518857.USD","LU0516422366.SGD","LU1675838814.USD","BK1141","LU1115378108.SGD","BK1583","LU1988902786.USD","00568","IE00B0169L03.USD","LU0211977185.USD","399300","LU0359201612.USD","LU2242644610.SGD","LU2476274720.SGD","LU0918141887.USD","LU2097828805.USD","688981","SG9999002463.SGD","LU0672654166.SGD","LU1188198961.HKD","LU3063872942.SGD","83130","LU0648948544.HKD","07233","BK1214","83188","00895","LU1224709979.USD","SGXZ49509284.SGD","LU0868486357.SGD","LU2097828557.USD","00956","IE0008368742.USD","LU0502904849.HKD","LU1211504680.USD","LU1769817179.HKD","LU0880133367.SGD","LU1064131003.USD","LU1993786604.SGD","LU0228367735.SGD","LU0307460666.USD","LU0320764599.SGD","LU0823426308.USD","06869","LU0488056044.USD","LU1807302812.USD","HK0000500386.USD","IE0034224299.USD","02691","LU1960683339.HKD","IE00B031HY20.USD","03678","LU0359202008.SGD","LU1048596156.SGD","LU0862451753.SGD","01057","159982","BK1163","BK0214","LU0572944931.SGD","BK1198","LU0620787316.HKD","LU0886674414.USD","LU0469268626.HKD","BK1171","LU0737861772.HKD","LU0231483743.USD","LU0348816934.USD","LU1282649067.USD","01108","LU2778985437.USD","LU0791591158.USD","HK0000252160.HKD","LU0561508036.HKD","03130","BK1576","SG9999011746.SGD","LU0327786744.USD","03200","LU1242518931.SGD","LU0348788117.USD","BK1507","LU0348766576.USD","LU1769817096.USD","BK1116","BK1564","HK0000352291.HKD","BK1551","02692","HK0000320223.HKD","LU0149534421.HKD","LU0821914370.USD","IE00BVYPNP33.GBP","BK1110","BK1592","06185","LU0588546209.SGD","LU0266512127.USD","03750","LU0456827905.SGD","03188","01349","IE00B29SXG58.USD","LU0072913022.USD","LU0314109678.HKD","LU2264538146.SGD","LU0370786039.SGD","LU0082770016.SGD","IE00BMCWC346.EUR","LU1244550577.SGD","LU0049853897.USD","LU1152091168.USD","BK1574","BK1161","BK1514","LU0039217434.USD","LU0463099449.HKD","LU0737861699.HKD","01812","03759","BK1231","LU0029875118.USD","IE00BZ08YR35.GBP","LU0501845795.SGD","LU0181495838.USD","LU0210526637.USD","LU0797268264.HKD","LU1282648689.USD","LU0828237510.HKD","02475","LU0164880469.USD","LU0348827113.USD","LU0607220059.USD","LU0708995583.HKD","LU1880383366.USD","LU0163747925.USD","LU0348805143.USD","SG9999001226.SGD","BK1554","BK1105","BK1506","01989","LU0164939612.USD","LU0254981946.USD","LU1961090484.USD","HK0001040143.USD","02899","BK1249","LU0348825331.USD","LU1064130708.USD","BK1594","LU0348814723.USD","LU0043850808.USD","LU1251922891.USD","LU2045819591.USD","LU1481107354.HKD","IE00B5MMRT66.SGD","LU0348735423.USD","LU0345780281.USD","LU1282649810.SGD","BK1537","BK1552","LU1366334578.USD","00981","IE00BVYPNQ40.USD","LU0384037296.USD","02846","LU0455707207.USD","LU2097828714.EUR","SG9999014674.SGD","03328","03986","LU0164865239.USD","LU0543330483.HKD","SG9999002828.SGD","IE0008369823.USD","LU2177674079.SGD","LU1328277881.USD","LU0266512473.USD","02338","LU0149721374.USD","LU1226287529.USD","LU2394011477.USD","SGXZ81163826.USD","HK0000320264.USD","LU1688375341.USD","LU1808992512.USD","LU0516423091.SGD","IE00BF5LJ272.USD","BK1191","LU1720050803.USD","02827","HK0000306701.USD","LU0048580855.USD","BK1166","LU0871576103.HKD","LU2399975544.HKD","LU0054450605.USD","BK1223","HK0000306685.HKD","LU1046422090.SGD","BK1521","IE00BZ08YT58.USD","LU0140636845.USD","BK1503","LU0417516902.SGD","LU1282649141.HKD","LU1303224171.USD","LU0791590937.USD","00916","LU0417516738.SGD","BK1560","LU0315179316.USD","BK1202","BK1505","LU1719994722.HKD","LU0117841782.USD","BK1607","BK1562","LU0061477393.USD","LU0823426480.USD","LU0516422952.EUR","LU0096374516.USD","LU1152091754.HKD","LU0593848301.USD","BK1237","BK1140","IE00B3M56506.USD","LU2097828474.EUR","LU0173614495.USD","LU0165289439.USD","LU0052750758.USD","LU0823040885.USD","SG9999001093.SGD","SG9999006597.SGD","LU0449509016.USD","LU0509642566.USD","LU1813983027.USD","LU0051755006.USD","LU0082770016.USD","HK0000252152.HKD","LU0531971595.HKD","LU0329678337.USD","09989","LU2148510915.USD","LU0287142896.SGD","LU2039709279.SGD","BK1546","LU0516422440.USD","LU1880383440.USD","02218","LU1794554557.SGD","LU0067412154.USD","SG9999004220.SGD","BK1147","BK1170","BK1154","IE00BZ08YS42.EUR","LU0128522157.USD","BK1149","BK1190","LU2294711473.HKD","IE00B031J352.USD","LU0828238088.HKD","00042","LU1831875114.USD","LU0634319403.HKD","LU2008162690.USD","03308","LU1244550221.USD","LU0918141705.HKD","LU0828237940.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162184322","title":"Citi Raises Keymed Bio's Target Price to HK$97.5, Maintains Buy/High-Risk Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1162184322","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162184322?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:54","pubTimestamp":1787298869,"startTime":"0","endTime":"0","summary":"Citi has released a research report highlighting that KEYMED BIO-B (02162) posted first-half 2026 revenue of RMB617 million, marking a 24% year-over-year increase. Notably, sales of stapokibart...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFNS","LU0477156953.USD","LU1244550494.USD","LU2456880835.USD","LU0052756011.USD","BK4588","LU0314106906.USD","BK4207","IE00BSNM7G36.USD","FTXO","LU0098860793.USD","LU1668664300.SGD","BK1574","BK1161","BK4585","LU2125154935.USD","C","IYF","LU1244550221.USD","BK4559","LU1074936037.SGD","LU1244550577.SGD","LU2125154778.USD","LU1267930227.SGD","LU1201861249.SGD","LU1366192091.USD","BK4534","BK4504","02162","LU0320765646.SGD","LU0170899867.USD","LU1506573853.SGD","LU2417539215.USD","LU2462157665.USD","BK1583","LU0203345920.USD","LU1791807156.HKD","LU2236285917.USD","LU0128525689.USD","BK4566","BK1587","LU0310800965.SGD","EWH","LU2360032135.SGD","LU0072461881.USD","LU0130102774.USD","LU0106831901.USD","LU0130517989.USD","LU0162691827.USD","LU1162221912.USD","LU0980610538.SGD","LU0648001328.SGD","LU0203347892.USD","LU1144417596.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250205","title":"3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250205","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250205?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:25","pubTimestamp":1787297118,"startTime":"0","endTime":"0","summary":"3SBio H1 FY26 net profit rises 26.5% to RMB 1.44 billion; revenue increases 3.9% to RMB 4.53 billion3SBio posted first-half 2026 revenue of RMB 4.53 billion, up 3.9% year over year.Net profit attribut","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLb6tQZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1583","BK1593","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250247","title":"Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250247?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:24","pubTimestamp":1787297040,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, represent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK4232","BK1161","01530","R","IDNA","HYLG","GDOC","NVIB","BK4022","HK0000165453.HKD","BMED","MEDX","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661825746","title":"Norway's Medistim Q2 Revenue Rises on Own-Product Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661825746","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661825746?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:40","pubTimestamp":1787294458,"startTime":"0","endTime":"0","summary":"Norway's Medistim Q2 revenue rises on own-product sales growthOverviewNorway medical device maker's Q2 revenue grew 19.5% yr/yr to NOK 202 mlnQ2 operating profit (EBIT) rose 20.6% to NOK 65.3 mln, EBI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I05U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","02190","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":28,"pageCount":24,"totalSize":546,"code":"91000000","status":"200"}]}}